Pacific South Morning Journal ®

by Gilman Jones & Lakshaya Grover his has been a topic of discussion amongst low cost healthcare activists in North America and Germany, Politicians and pharmaceutical companies alike. It is indeed true that the cost of many drugs is significantly lower in India compared to not only America, but the whole world. The primary factor that bloats up the cost of medicines in USA is the strong patent laws that protect the right of industry giants to monopolise the production of important drugs. This results in the pharma corporations demanding exorbitant amounts of money for essential life saving drugs. United States has been a pioneer in developing new drugs and treatments, but the issue of corporate monopoly over the cost and distributions has stultified the dissipation of effective treatment to the ones who actually need it. The pharmaceutical companies, in a nexus with healthcare insurance companies artificially inflate the cost of drugs and often deprive the needy of healt